nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP2E1—Etoposide—testicular cancer	0.0729	0.179	CbGbCtD
Fluphenazine—ABCB1—Dactinomycin—testicular cancer	0.0653	0.16	CbGbCtD
Fluphenazine—CYP1A2—Etoposide—testicular cancer	0.0421	0.103	CbGbCtD
Fluphenazine—ABCB1—Vinblastine—testicular cancer	0.0409	0.1	CbGbCtD
Fluphenazine—CYP2D6—Vinblastine—testicular cancer	0.0385	0.0946	CbGbCtD
Fluphenazine—ABCB1—Cisplatin—testicular cancer	0.0375	0.0921	CbGbCtD
Fluphenazine—ABCB1—Etoposide—testicular cancer	0.0369	0.0905	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—testicular cancer	0.0251	0.0617	CbGbCtD
Fluphenazine—ABCB1—Methotrexate—testicular cancer	0.0243	0.0598	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—testicular cancer	0.0237	0.0581	CbGbCtD
Fluphenazine—CALM2—semen—testicular cancer	0.022	0.147	CbGeAlD
Fluphenazine—CALM1—semen—testicular cancer	0.0219	0.146	CbGeAlD
Fluphenazine—HTR2A—vein—testicular cancer	0.0159	0.106	CbGeAlD
Fluphenazine—CALM3—seminal vesicle—testicular cancer	0.00594	0.0396	CbGeAlD
Fluphenazine—Faecaloma—Doxorubicin—testicular cancer	0.00502	0.0125	CcSEcCtD
Fluphenazine—Faecalith—Doxorubicin—testicular cancer	0.00502	0.0125	CcSEcCtD
Fluphenazine—CALM2—embryo—testicular cancer	0.00496	0.0331	CbGeAlD
Fluphenazine—CALM1—embryo—testicular cancer	0.00494	0.033	CbGeAlD
Fluphenazine—Tenderness—Bleomycin—testicular cancer	0.0047	0.0117	CcSEcCtD
Fluphenazine—CALM2—seminal vesicle—testicular cancer	0.00466	0.0311	CbGeAlD
Fluphenazine—Extrapyramidal disorder—Ifosfamide—testicular cancer	0.00465	0.0116	CcSEcCtD
Fluphenazine—Pigmentation disorder—Epirubicin—testicular cancer	0.00465	0.0115	CcSEcCtD
Fluphenazine—Pigmentation disorder—Doxorubicin—testicular cancer	0.0043	0.0107	CcSEcCtD
Fluphenazine—Renal failure acute—Chlorambucil—testicular cancer	0.00416	0.0103	CcSEcCtD
Fluphenazine—Tenderness—Ifosfamide—testicular cancer	0.00401	0.00997	CcSEcCtD
Fluphenazine—Dyskinesia—Ifosfamide—testicular cancer	0.00373	0.00926	CcSEcCtD
Fluphenazine—Liver injury—Cisplatin—testicular cancer	0.00359	0.00891	CcSEcCtD
Fluphenazine—CALM3—female gonad—testicular cancer	0.00349	0.0233	CbGeAlD
Fluphenazine—Tenderness—Cisplatin—testicular cancer	0.00346	0.0086	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Ifosfamide—testicular cancer	0.0034	0.00845	CcSEcCtD
Fluphenazine—CALM2—gonad—testicular cancer	0.00337	0.0225	CbGeAlD
Fluphenazine—CALM1—gonad—testicular cancer	0.00335	0.0224	CbGeAlD
Fluphenazine—Appetite absent—Methotrexate—testicular cancer	0.00333	0.00827	CcSEcCtD
Fluphenazine—ADRA2A—seminal vesicle—testicular cancer	0.00332	0.0222	CbGeAlD
Fluphenazine—CYP2E1—seminal vesicle—testicular cancer	0.00325	0.0217	CbGeAlD
Fluphenazine—Urine output increased—Ifosfamide—testicular cancer	0.00317	0.00787	CcSEcCtD
Fluphenazine—Pancytopenia—Chlorambucil—testicular cancer	0.00316	0.00784	CcSEcCtD
Fluphenazine—CALM3—testis—testicular cancer	0.00309	0.0206	CbGeAlD
Fluphenazine—Hepatocellular injury—Cisplatin—testicular cancer	0.00302	0.0075	CcSEcCtD
Fluphenazine—HTR2A—embryo—testicular cancer	0.00301	0.0201	CbGeAlD
Fluphenazine—Pneumonia—Chlorambucil—testicular cancer	0.00298	0.0074	CcSEcCtD
Fluphenazine—Body temperature increased—Carboplatin—testicular cancer	0.0029	0.00721	CcSEcCtD
Fluphenazine—Polyuria—Ifosfamide—testicular cancer	0.0029	0.00719	CcSEcCtD
Fluphenazine—Pancytopenia—Vinblastine—testicular cancer	0.00289	0.00718	CcSEcCtD
Fluphenazine—Lethargy—Dactinomycin—testicular cancer	0.00283	0.00703	CcSEcCtD
Fluphenazine—Renal failure acute—Ifosfamide—testicular cancer	0.00275	0.00684	CcSEcCtD
Fluphenazine—CALM2—female gonad—testicular cancer	0.00274	0.0183	CbGeAlD
Fluphenazine—CALM1—female gonad—testicular cancer	0.00272	0.0182	CbGeAlD
Fluphenazine—Agranulocytosis—Vinblastine—testicular cancer	0.00253	0.00629	CcSEcCtD
Fluphenazine—Polyuria—Cisplatin—testicular cancer	0.0025	0.0062	CcSEcCtD
Fluphenazine—Pancytopenia—Bleomycin—testicular cancer	0.00244	0.00607	CcSEcCtD
Fluphenazine—CALM2—testis—testicular cancer	0.00243	0.0162	CbGeAlD
Fluphenazine—Cardiac arrest—Ifosfamide—testicular cancer	0.00242	0.00601	CcSEcCtD
Fluphenazine—CALM1—testis—testicular cancer	0.00242	0.0161	CbGeAlD
Fluphenazine—Nasal congestion—Cisplatin—testicular cancer	0.00241	0.00598	CcSEcCtD
Fluphenazine—ADRA2A—gonad—testicular cancer	0.0024	0.016	CbGeAlD
Fluphenazine—Dysphagia—Dactinomycin—testicular cancer	0.0024	0.00596	CcSEcCtD
Fluphenazine—Renal failure acute—Cisplatin—testicular cancer	0.00237	0.0059	CcSEcCtD
Fluphenazine—Pneumonia—Bleomycin—testicular cancer	0.00231	0.00573	CcSEcCtD
Fluphenazine—Pancytopenia—Dactinomycin—testicular cancer	0.00228	0.00566	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Epirubicin—testicular cancer	0.00228	0.00565	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Cisplatin—testicular cancer	0.00226	0.00563	CcSEcCtD
Fluphenazine—CALM3—lymph node—testicular cancer	0.00224	0.015	CbGeAlD
Fluphenazine—DRD2—testis—testicular cancer	0.00223	0.0149	CbGeAlD
Fluphenazine—Pneumonia—Dactinomycin—testicular cancer	0.00215	0.00534	CcSEcCtD
Fluphenazine—Agitation—Chlorambucil—testicular cancer	0.00213	0.00528	CcSEcCtD
Fluphenazine—Angioedema—Chlorambucil—testicular cancer	0.00212	0.00525	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—testicular cancer	0.00211	0.00523	CcSEcCtD
Fluphenazine—Dermatitis atopic—Epirubicin—testicular cancer	0.0021	0.0052	CcSEcCtD
Fluphenazine—Pancytopenia—Ifosfamide—testicular cancer	0.00209	0.00518	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Etoposide—testicular cancer	0.00207	0.00515	CcSEcCtD
Fluphenazine—Leukopenia—Chlorambucil—testicular cancer	0.00207	0.00515	CcSEcCtD
Fluphenazine—HTR2A—gonad—testicular cancer	0.00204	0.0136	CbGeAlD
Fluphenazine—Agranulocytosis—Dactinomycin—testicular cancer	0.002	0.00496	CcSEcCtD
Fluphenazine—HRH1—female gonad—testicular cancer	0.00199	0.0133	CbGeAlD
Fluphenazine—ABCB1—embryo—testicular cancer	0.00197	0.0132	CbGeAlD
Fluphenazine—Pneumonia—Ifosfamide—testicular cancer	0.00197	0.0049	CcSEcCtD
Fluphenazine—ADRA2A—female gonad—testicular cancer	0.00195	0.013	CbGeAlD
Fluphenazine—Dermatitis atopic—Doxorubicin—testicular cancer	0.00194	0.00482	CcSEcCtD
Fluphenazine—Cardiac arrest—Etoposide—testicular cancer	0.00191	0.00474	CcSEcCtD
Fluphenazine—Leukopenia—Vinblastine—testicular cancer	0.0019	0.00472	CcSEcCtD
Fluphenazine—Blood disorder—Epirubicin—testicular cancer	0.00186	0.00461	CcSEcCtD
Fluphenazine—ABCB1—seminal vesicle—testicular cancer	0.00185	0.0124	CbGeAlD
Fluphenazine—Liver injury—Epirubicin—testicular cancer	0.00184	0.00458	CcSEcCtD
Fluphenazine—Hypertension—Vinblastine—testicular cancer	0.00183	0.00455	CcSEcCtD
Fluphenazine—Agranulocytosis—Ifosfamide—testicular cancer	0.00183	0.00454	CcSEcCtD
Fluphenazine—Pancytopenia—Cisplatin—testicular cancer	0.0018	0.00447	CcSEcCtD
Fluphenazine—Erythema—Bleomycin—testicular cancer	0.00179	0.00445	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Epirubicin—testicular cancer	0.00176	0.00438	CcSEcCtD
Fluphenazine—HRH1—testis—testicular cancer	0.00176	0.0118	CbGeAlD
Fluphenazine—CALM2—lymph node—testicular cancer	0.00176	0.0117	CbGeAlD
Fluphenazine—CALM1—lymph node—testicular cancer	0.00175	0.0117	CbGeAlD
Fluphenazine—Dysphagia—Etoposide—testicular cancer	0.00174	0.00431	CcSEcCtD
Fluphenazine—ADRA2A—testis—testicular cancer	0.00173	0.0116	CbGeAlD
Fluphenazine—Blood disorder—Doxorubicin—testicular cancer	0.00172	0.00427	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—testicular cancer	0.00171	0.00424	CcSEcCtD
Fluphenazine—CYP2E1—testis—testicular cancer	0.00169	0.0113	CbGeAlD
Fluphenazine—Erythema—Dactinomycin—testicular cancer	0.00167	0.00415	CcSEcCtD
Fluphenazine—Dyskinesia—Epirubicin—testicular cancer	0.00165	0.0041	CcSEcCtD
Fluphenazine—Pancytopenia—Etoposide—testicular cancer	0.00165	0.00409	CcSEcCtD
Fluphenazine—Decreased appetite—Chlorambucil—testicular cancer	0.00164	0.00408	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00163	0.00406	CcSEcCtD
Fluphenazine—Leukopenia—Bleomycin—testicular cancer	0.0016	0.00398	CcSEcCtD
Fluphenazine—Pneumonia—Etoposide—testicular cancer	0.00156	0.00387	CcSEcCtD
Fluphenazine—Hepatocellular injury—Epirubicin—testicular cancer	0.00155	0.00385	CcSEcCtD
Fluphenazine—Abnormal dreams—Epirubicin—testicular cancer	0.00153	0.00381	CcSEcCtD
Fluphenazine—Erythema—Ifosfamide—testicular cancer	0.00153	0.0038	CcSEcCtD
Fluphenazine—Dyskinesia—Doxorubicin—testicular cancer	0.00153	0.00379	CcSEcCtD
Fluphenazine—CYP2D6—female gonad—testicular cancer	0.00151	0.0101	CbGeAlD
Fluphenazine—Salivary hypersecretion—Epirubicin—testicular cancer	0.00151	0.00374	CcSEcCtD
Fluphenazine—Decreased appetite—Vinblastine—testicular cancer	0.00151	0.00374	CcSEcCtD
Fluphenazine—Urticaria—Chlorambucil—testicular cancer	0.0015	0.00373	CcSEcCtD
Fluphenazine—Urine output increased—Methotrexate—testicular cancer	0.0015	0.00372	CcSEcCtD
Fluphenazine—Leukopenia—Dactinomycin—testicular cancer	0.0015	0.00372	CcSEcCtD
Fluphenazine—Body temperature increased—Chlorambucil—testicular cancer	0.00149	0.00371	CcSEcCtD
Fluphenazine—Gynaecomastia—Methotrexate—testicular cancer	0.00148	0.00368	CcSEcCtD
Fluphenazine—Constipation—Vinblastine—testicular cancer	0.00148	0.00368	CcSEcCtD
Fluphenazine—HTR2A—testis—testicular cancer	0.00147	0.00983	CbGeAlD
Fluphenazine—Anaphylactic shock—Bleomycin—testicular cancer	0.00146	0.00363	CcSEcCtD
Fluphenazine—Agranulocytosis—Etoposide—testicular cancer	0.00144	0.00359	CcSEcCtD
Fluphenazine—Vision blurred—Ifosfamide—testicular cancer	0.00144	0.00358	CcSEcCtD
Fluphenazine—Hepatocellular injury—Doxorubicin—testicular cancer	0.00144	0.00356	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—testicular cancer	0.00142	0.00352	CcSEcCtD
Fluphenazine—Agitation—Ifosfamide—testicular cancer	0.00141	0.0035	CcSEcCtD
Fluphenazine—Angioedema—Ifosfamide—testicular cancer	0.0014	0.00348	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Doxorubicin—testicular cancer	0.00139	0.00346	CcSEcCtD
Fluphenazine—Hypersensitivity—Chlorambucil—testicular cancer	0.00139	0.00346	CcSEcCtD
Fluphenazine—Leukopenia—Ifosfamide—testicular cancer	0.00137	0.0034	CcSEcCtD
Fluphenazine—Polyuria—Methotrexate—testicular cancer	0.00137	0.0034	CcSEcCtD
Fluphenazine—Photosensitivity—Methotrexate—testicular cancer	0.00137	0.0034	CcSEcCtD
Fluphenazine—Hypotension—Bleomycin—testicular cancer	0.00137	0.00339	CcSEcCtD
Fluphenazine—CYP2D6—testis—testicular cancer	0.00134	0.00895	CbGeAlD
Fluphenazine—ABCB1—gonad—testicular cancer	0.00134	0.00894	CbGeAlD
Fluphenazine—Pruritus—Chlorambucil—testicular cancer	0.00134	0.00332	CcSEcCtD
Fluphenazine—Hypertension—Ifosfamide—testicular cancer	0.00132	0.00328	CcSEcCtD
Fluphenazine—Erythema—Cisplatin—testicular cancer	0.00132	0.00328	CcSEcCtD
Fluphenazine—Dyspnoea—Bleomycin—testicular cancer	0.0013	0.00324	CcSEcCtD
Fluphenazine—Renal failure acute—Methotrexate—testicular cancer	0.0013	0.00324	CcSEcCtD
Fluphenazine—Photosensitivity—Epirubicin—testicular cancer	0.00128	0.00318	CcSEcCtD
Fluphenazine—HRH1—lymph node—testicular cancer	0.00128	0.00853	CbGeAlD
Fluphenazine—Hypersensitivity—Vinblastine—testicular cancer	0.00128	0.00317	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Methotrexate—testicular cancer	0.00127	0.00317	CcSEcCtD
Fluphenazine—Decreased appetite—Bleomycin—testicular cancer	0.00127	0.00316	CcSEcCtD
Fluphenazine—Muscle spasms—Cisplatin—testicular cancer	0.00127	0.00315	CcSEcCtD
Fluphenazine—ADRA2A—lymph node—testicular cancer	0.00126	0.00838	CbGeAlD
Fluphenazine—Eczema—Epirubicin—testicular cancer	0.00125	0.00311	CcSEcCtD
Fluphenazine—Anaphylactic shock—Ifosfamide—testicular cancer	0.00125	0.0031	CcSEcCtD
Fluphenazine—Vision blurred—Cisplatin—testicular cancer	0.00124	0.00309	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00124	0.00309	CcSEcCtD
Fluphenazine—Lethargy—Methotrexate—testicular cancer	0.00123	0.00305	CcSEcCtD
Fluphenazine—Renal failure acute—Epirubicin—testicular cancer	0.00122	0.00303	CcSEcCtD
Fluphenazine—Skin disorder—Ifosfamide—testicular cancer	0.00121	0.00302	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00119	0.00296	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—testicular cancer	0.00119	0.00295	CcSEcCtD
Fluphenazine—Decreased appetite—Dactinomycin—testicular cancer	0.00119	0.00294	CcSEcCtD
Fluphenazine—Leukopenia—Cisplatin—testicular cancer	0.00118	0.00294	CcSEcCtD
Fluphenazine—Hypotension—Ifosfamide—testicular cancer	0.00117	0.0029	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00116	0.00289	CcSEcCtD
Fluphenazine—Muscle spasms—Etoposide—testicular cancer	0.00116	0.00289	CcSEcCtD
Fluphenazine—Urticaria—Bleomycin—testicular cancer	0.00116	0.00289	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—testicular cancer	0.00116	0.00288	CcSEcCtD
Fluphenazine—Body temperature increased—Bleomycin—testicular cancer	0.00116	0.00287	CcSEcCtD
Fluphenazine—Lethargy—Epirubicin—testicular cancer	0.00115	0.00285	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—testicular cancer	0.00113	0.0028	CcSEcCtD
Fluphenazine—Nausea—Chlorambucil—testicular cancer	0.00112	0.00279	CcSEcCtD
Fluphenazine—Dyspnoea—Ifosfamide—testicular cancer	0.00111	0.00277	CcSEcCtD
Fluphenazine—Somnolence—Ifosfamide—testicular cancer	0.00111	0.00276	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.0011	0.00274	CcSEcCtD
Fluphenazine—ABCB1—female gonad—testicular cancer	0.00109	0.00726	CbGeAlD
Fluphenazine—Decreased appetite—Ifosfamide—testicular cancer	0.00109	0.0027	CcSEcCtD
Fluphenazine—Headache—Vinblastine—testicular cancer	0.00108	0.00269	CcSEcCtD
Fluphenazine—Leukopenia—Etoposide—testicular cancer	0.00108	0.00269	CcSEcCtD
Fluphenazine—Body temperature increased—Dactinomycin—testicular cancer	0.00108	0.00268	CcSEcCtD
Fluphenazine—Anaphylactic shock—Cisplatin—testicular cancer	0.00108	0.00268	CcSEcCtD
Fluphenazine—Hypersensitivity—Bleomycin—testicular cancer	0.00108	0.00268	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00108	0.00267	CcSEcCtD
Fluphenazine—Cardiac arrest—Epirubicin—testicular cancer	0.00107	0.00266	CcSEcCtD
Fluphenazine—Constipation—Ifosfamide—testicular cancer	0.00107	0.00265	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—testicular cancer	0.00106	0.00264	CcSEcCtD
Fluphenazine—Tachycardia—Cisplatin—testicular cancer	0.00105	0.00261	CcSEcCtD
Fluphenazine—Skin disorder—Cisplatin—testicular cancer	0.00105	0.0026	CcSEcCtD
Fluphenazine—Hypertension—Etoposide—testicular cancer	0.00104	0.00259	CcSEcCtD
Fluphenazine—Asthma—Methotrexate—testicular cancer	0.00104	0.00258	CcSEcCtD
Fluphenazine—Pruritus—Bleomycin—testicular cancer	0.00103	0.00257	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—testicular cancer	0.00103	0.00256	CcSEcCtD
Fluphenazine—Nausea—Vinblastine—testicular cancer	0.00103	0.00255	CcSEcCtD
Fluphenazine—Hypotension—Cisplatin—testicular cancer	0.00101	0.0025	CcSEcCtD
Fluphenazine—Hypersensitivity—Dactinomycin—testicular cancer	0.001	0.0025	CcSEcCtD
Fluphenazine—Urticaria—Ifosfamide—testicular cancer	0.000993	0.00247	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—testicular cancer	0.00099	0.00246	CcSEcCtD
Fluphenazine—Body temperature increased—Ifosfamide—testicular cancer	0.000988	0.00245	CcSEcCtD
Fluphenazine—Pancytopenia—Methotrexate—testicular cancer	0.000987	0.00245	CcSEcCtD
Fluphenazine—Anaphylactic shock—Etoposide—testicular cancer	0.000987	0.00245	CcSEcCtD
Fluphenazine—Dysphagia—Epirubicin—testicular cancer	0.000973	0.00242	CcSEcCtD
Fluphenazine—Asthma—Epirubicin—testicular cancer	0.000973	0.00242	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000966	0.0024	CcSEcCtD
Fluphenazine—ABCB1—testis—testicular cancer	0.000965	0.00644	CbGeAlD
Fluphenazine—Tachycardia—Etoposide—testicular cancer	0.000963	0.00239	CcSEcCtD
Fluphenazine—Eosinophilia—Epirubicin—testicular cancer	0.000963	0.00239	CcSEcCtD
Fluphenazine—Dyspnoea—Cisplatin—testicular cancer	0.000961	0.00239	CcSEcCtD
Fluphenazine—Skin disorder—Etoposide—testicular cancer	0.000959	0.00238	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—testicular cancer	0.000949	0.00236	CcSEcCtD
Fluphenazine—Decreased appetite—Cisplatin—testicular cancer	0.000937	0.00233	CcSEcCtD
Fluphenazine—Pneumonia—Methotrexate—testicular cancer	0.000932	0.00232	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—testicular cancer	0.000927	0.0023	CcSEcCtD
Fluphenazine—Pancytopenia—Epirubicin—testicular cancer	0.000924	0.0023	CcSEcCtD
Fluphenazine—Hypotension—Etoposide—testicular cancer	0.000922	0.00229	CcSEcCtD
Fluphenazine—Hypersensitivity—Ifosfamide—testicular cancer	0.000921	0.00229	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000904	0.00225	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—testicular cancer	0.0009	0.00224	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—testicular cancer	0.0009	0.00224	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—testicular cancer	0.000891	0.00221	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Epirubicin—testicular cancer	0.000888	0.00221	CcSEcCtD
Fluphenazine—Pruritus—Ifosfamide—testicular cancer	0.000884	0.0022	CcSEcCtD
Fluphenazine—Dyspnoea—Etoposide—testicular cancer	0.00088	0.00219	CcSEcCtD
Fluphenazine—Somnolence—Etoposide—testicular cancer	0.000877	0.00218	CcSEcCtD
Fluphenazine—Pneumonia—Epirubicin—testicular cancer	0.000873	0.00217	CcSEcCtD
Fluphenazine—Nausea—Bleomycin—testicular cancer	0.000869	0.00216	CcSEcCtD
Fluphenazine—Drowsiness—Epirubicin—testicular cancer	0.000868	0.00215	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—testicular cancer	0.000865	0.00215	CcSEcCtD
Fluphenazine—Decreased appetite—Etoposide—testicular cancer	0.000858	0.00213	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—testicular cancer	0.000855	0.00212	CcSEcCtD
Fluphenazine—Body temperature increased—Cisplatin—testicular cancer	0.000852	0.00212	CcSEcCtD
Fluphenazine—Constipation—Etoposide—testicular cancer	0.000844	0.0021	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000837	0.00208	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000822	0.00204	CcSEcCtD
Fluphenazine—Nausea—Dactinomycin—testicular cancer	0.00081	0.00201	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—testicular cancer	0.00081	0.00201	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—testicular cancer	0.000807	0.00201	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—testicular cancer	0.000803	0.00199	CcSEcCtD
Fluphenazine—Hypersensitivity—Cisplatin—testicular cancer	0.000794	0.00197	CcSEcCtD
Fluphenazine—Urticaria—Etoposide—testicular cancer	0.000784	0.00195	CcSEcCtD
Fluphenazine—Body temperature increased—Etoposide—testicular cancer	0.00078	0.00194	CcSEcCtD
Fluphenazine—Oedema peripheral—Epirubicin—testicular cancer	0.000767	0.00191	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—testicular cancer	0.000749	0.00186	CcSEcCtD
Fluphenazine—Nausea—Ifosfamide—testicular cancer	0.000742	0.00184	CcSEcCtD
Fluphenazine—Hypersensitivity—Etoposide—testicular cancer	0.000727	0.00181	CcSEcCtD
Fluphenazine—Erythema—Methotrexate—testicular cancer	0.000724	0.0018	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—testicular cancer	0.00071	0.00176	CcSEcCtD
Fluphenazine—ABCB1—lymph node—testicular cancer	0.000699	0.00467	CbGeAlD
Fluphenazine—Pruritus—Etoposide—testicular cancer	0.000698	0.00173	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—testicular cancer	0.000683	0.0017	CcSEcCtD
Fluphenazine—Erythema—Epirubicin—testicular cancer	0.000678	0.00168	CcSEcCtD
Fluphenazine—Muscle spasms—Epirubicin—testicular cancer	0.000652	0.00162	CcSEcCtD
Fluphenazine—Leukopenia—Methotrexate—testicular cancer	0.000648	0.00161	CcSEcCtD
Fluphenazine—Nausea—Cisplatin—testicular cancer	0.00064	0.00159	CcSEcCtD
Fluphenazine—Vision blurred—Epirubicin—testicular cancer	0.000639	0.00159	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—testicular cancer	0.000627	0.00156	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—testicular cancer	0.000623	0.00155	CcSEcCtD
Fluphenazine—Headache—Etoposide—testicular cancer	0.000618	0.00154	CcSEcCtD
Fluphenazine—Leukopenia—Epirubicin—testicular cancer	0.000607	0.00151	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—testicular cancer	0.000603	0.0015	CcSEcCtD
Fluphenazine—Anaphylactic shock—Methotrexate—testicular cancer	0.000591	0.00147	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—testicular cancer	0.000591	0.00147	CcSEcCtD
Fluphenazine—Nausea—Etoposide—testicular cancer	0.000586	0.00146	CcSEcCtD
Fluphenazine—Hypertension—Epirubicin—testicular cancer	0.000585	0.00145	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—testicular cancer	0.000576	0.00143	CcSEcCtD
Fluphenazine—Skin disorder—Methotrexate—testicular cancer	0.000574	0.00143	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—testicular cancer	0.000564	0.0014	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—testicular cancer	0.000561	0.00139	CcSEcCtD
Fluphenazine—Anaphylactic shock—Epirubicin—testicular cancer	0.000553	0.00137	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—testicular cancer	0.000552	0.00137	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—testicular cancer	0.000542	0.00135	CcSEcCtD
Fluphenazine—Tachycardia—Epirubicin—testicular cancer	0.00054	0.00134	CcSEcCtD
Fluphenazine—Skin disorder—Epirubicin—testicular cancer	0.000537	0.00133	CcSEcCtD
Fluphenazine—Dyspnoea—Methotrexate—testicular cancer	0.000527	0.00131	CcSEcCtD
Fluphenazine—Somnolence—Methotrexate—testicular cancer	0.000526	0.00131	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—testicular cancer	0.000522	0.0013	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—testicular cancer	0.000517	0.00128	CcSEcCtD
Fluphenazine—Decreased appetite—Methotrexate—testicular cancer	0.000514	0.00128	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000512	0.00127	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—testicular cancer	0.0005	0.00124	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—testicular cancer	0.000497	0.00124	CcSEcCtD
Fluphenazine—Dyspnoea—Epirubicin—testicular cancer	0.000493	0.00123	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—testicular cancer	0.000492	0.00122	CcSEcCtD
Fluphenazine—Decreased appetite—Epirubicin—testicular cancer	0.000481	0.00119	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—testicular cancer	0.000478	0.00119	CcSEcCtD
Fluphenazine—Constipation—Epirubicin—testicular cancer	0.000473	0.00118	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—testicular cancer	0.00047	0.00117	CcSEcCtD
Fluphenazine—Body temperature increased—Methotrexate—testicular cancer	0.000467	0.00116	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—testicular cancer	0.000456	0.00113	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—testicular cancer	0.000455	0.00113	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—testicular cancer	0.000445	0.00111	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—testicular cancer	0.00044	0.00109	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—testicular cancer	0.000438	0.00109	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—testicular cancer	0.000437	0.00109	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—testicular cancer	0.000436	0.00108	CcSEcCtD
Fluphenazine—Pruritus—Methotrexate—testicular cancer	0.000418	0.00104	CcSEcCtD
Fluphenazine—Hypersensitivity—Epirubicin—testicular cancer	0.000408	0.00101	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—testicular cancer	0.000407	0.00101	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—testicular cancer	0.000405	0.00101	CcSEcCtD
Fluphenazine—Pruritus—Epirubicin—testicular cancer	0.000391	0.000972	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—testicular cancer	0.000377	0.000937	CcSEcCtD
Fluphenazine—Headache—Methotrexate—testicular cancer	0.00037	0.00092	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—testicular cancer	0.000362	0.0009	CcSEcCtD
Fluphenazine—Nausea—Methotrexate—testicular cancer	0.000351	0.000872	CcSEcCtD
Fluphenazine—Headache—Epirubicin—testicular cancer	0.000347	0.000861	CcSEcCtD
Fluphenazine—Nausea—Epirubicin—testicular cancer	0.000329	0.000816	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—testicular cancer	0.000321	0.000797	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—testicular cancer	0.000304	0.000755	CcSEcCtD
Fluphenazine—CALM1—Signaling by EGFR—KITLG—testicular cancer	0.000141	0.00349	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000139	0.00345	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000139	0.00345	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by PDGF—KITLG—testicular cancer	0.000139	0.00344	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by PDGF—KITLG—testicular cancer	0.000139	0.00344	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—INSL3—testicular cancer	0.000137	0.0034	CbGpPWpGaD
Fluphenazine—CALM3—B Cell Activation—KITLG—testicular cancer	0.000136	0.00336	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—INSL3—testicular cancer	0.000135	0.00335	CbGpPWpGaD
Fluphenazine—CYP1A2—Biological oxidations—HPGDS—testicular cancer	0.000135	0.00335	CbGpPWpGaD
Fluphenazine—CALM2—B Cell Activation—KITLG—testicular cancer	0.000131	0.00325	CbGpPWpGaD
Fluphenazine—CALM1—B Cell Activation—KITLG—testicular cancer	0.000131	0.00325	CbGpPWpGaD
Fluphenazine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000131	0.00324	CbGpPWpGaD
Fluphenazine—CALM3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.00013	0.00322	CbGpPWpGaD
Fluphenazine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000126	0.00313	CbGpPWpGaD
Fluphenazine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000126	0.00313	CbGpPWpGaD
Fluphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000126	0.00311	CbGpPWpGaD
Fluphenazine—CALM2—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000126	0.00311	CbGpPWpGaD
Fluphenazine—CALM3—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000125	0.0031	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—INSL3—testicular cancer	0.000123	0.00306	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000121	0.00301	CbGpPWpGaD
Fluphenazine—CALM2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000121	0.003	CbGpPWpGaD
Fluphenazine—CALM1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000121	0.003	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—INSL3—testicular cancer	0.000119	0.00296	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—INSL3—testicular cancer	0.000119	0.00296	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—INSL3—testicular cancer	0.000118	0.00293	CbGpPWpGaD
Fluphenazine—CALM3—Downstream signal transduction—FGFR3—testicular cancer	0.000118	0.00291	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000117	0.00291	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000117	0.00291	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by FGFR—FGFR3—testicular cancer	0.000117	0.0029	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—INSL3—testicular cancer	0.000117	0.00289	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by ERBB2—FGFR3—testicular cancer	0.000116	0.00289	CbGpPWpGaD
Fluphenazine—CALM3—DAP12 signaling—FGFR3—testicular cancer	0.000116	0.00287	CbGpPWpGaD
Fluphenazine—CALM3—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000115	0.00285	CbGpPWpGaD
Fluphenazine—CALM1—Downstream signal transduction—FGFR3—testicular cancer	0.000114	0.00282	CbGpPWpGaD
Fluphenazine—CALM2—Downstream signal transduction—FGFR3—testicular cancer	0.000114	0.00282	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by FGFR—FGFR3—testicular cancer	0.000113	0.00281	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by FGFR—FGFR3—testicular cancer	0.000113	0.00281	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000113	0.0028	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by ERBB2—FGFR3—testicular cancer	0.000113	0.00279	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by ERBB2—FGFR3—testicular cancer	0.000113	0.00279	CbGpPWpGaD
Fluphenazine—CALM1—DAP12 signaling—FGFR3—testicular cancer	0.000112	0.00278	CbGpPWpGaD
Fluphenazine—CALM2—DAP12 signaling—FGFR3—testicular cancer	0.000112	0.00278	CbGpPWpGaD
Fluphenazine—CALM2—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000111	0.00275	CbGpPWpGaD
Fluphenazine—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000111	0.00275	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000109	0.0027	CbGpPWpGaD
Fluphenazine—CALM3—DAP12 interactions—FGFR3—testicular cancer	0.000109	0.0027	CbGpPWpGaD
Fluphenazine—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000109	0.0027	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by EGFR—FGFR3—testicular cancer	0.000108	0.00268	CbGpPWpGaD
Fluphenazine—CALM3—Downstream signal transduction—KIT—testicular cancer	0.000108	0.00268	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by FGFR—KIT—testicular cancer	0.000107	0.00266	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000107	0.00265	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by ERBB2—KIT—testicular cancer	0.000107	0.00265	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by PDGF—FGFR3—testicular cancer	0.000107	0.00264	CbGpPWpGaD
Fluphenazine—CALM3—DAP12 signaling—KIT—testicular cancer	0.000106	0.00264	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000105	0.00261	CbGpPWpGaD
Fluphenazine—CALM1—DAP12 interactions—FGFR3—testicular cancer	0.000105	0.00261	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000105	0.00261	CbGpPWpGaD
Fluphenazine—CALM2—DAP12 interactions—FGFR3—testicular cancer	0.000105	0.00261	CbGpPWpGaD
Fluphenazine—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000105	0.00261	CbGpPWpGaD
Fluphenazine—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000105	0.00261	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by EGFR—FGFR3—testicular cancer	0.000105	0.00259	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by EGFR—FGFR3—testicular cancer	0.000105	0.00259	CbGpPWpGaD
Fluphenazine—CALM2—Downstream signal transduction—KIT—testicular cancer	0.000104	0.00259	CbGpPWpGaD
Fluphenazine—CALM1—Downstream signal transduction—KIT—testicular cancer	0.000104	0.00259	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by FGFR—KIT—testicular cancer	0.000104	0.00258	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by FGFR—KIT—testicular cancer	0.000104	0.00258	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000104	0.00257	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000104	0.00257	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by ERBB2—KIT—testicular cancer	0.000103	0.00256	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by ERBB2—KIT—testicular cancer	0.000103	0.00256	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by PDGF—FGFR3—testicular cancer	0.000103	0.00256	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by PDGF—FGFR3—testicular cancer	0.000103	0.00256	CbGpPWpGaD
Fluphenazine—CALM1—DAP12 signaling—KIT—testicular cancer	0.000103	0.00255	CbGpPWpGaD
Fluphenazine—CALM2—DAP12 signaling—KIT—testicular cancer	0.000103	0.00255	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—INSL3—testicular cancer	0.000102	0.00252	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—INSL3—testicular cancer	0.000101	0.00251	CbGpPWpGaD
Fluphenazine—CALM3—B Cell Activation—FGFR3—testicular cancer	0.000101	0.0025	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	0.0001	0.00248	CbGpPWpGaD
Fluphenazine—CALM3—DAP12 interactions—KIT—testicular cancer	0.0001	0.00248	CbGpPWpGaD
Fluphenazine—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.0001	0.00248	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	0.0001	0.00248	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by NGF—KITLG—testicular cancer	9.99e-05	0.00248	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by EGFR—KIT—testicular cancer	9.92e-05	0.00246	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	9.83e-05	0.00244	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by PDGF—KIT—testicular cancer	9.79e-05	0.00243	CbGpPWpGaD
Fluphenazine—CALM2—B Cell Activation—FGFR3—testicular cancer	9.76e-05	0.00242	CbGpPWpGaD
Fluphenazine—CALM1—B Cell Activation—FGFR3—testicular cancer	9.76e-05	0.00242	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	9.68e-05	0.0024	CbGpPWpGaD
Fluphenazine—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	9.68e-05	0.0024	CbGpPWpGaD
Fluphenazine—CALM2—DAP12 interactions—KIT—testicular cancer	9.68e-05	0.0024	CbGpPWpGaD
Fluphenazine—CALM1—DAP12 interactions—KIT—testicular cancer	9.68e-05	0.0024	CbGpPWpGaD
Fluphenazine—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	9.68e-05	0.0024	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	9.68e-05	0.0024	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	9.68e-05	0.0024	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	9.68e-05	0.0024	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by NGF—KITLG—testicular cancer	9.67e-05	0.0024	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by NGF—KITLG—testicular cancer	9.67e-05	0.0024	CbGpPWpGaD
Fluphenazine—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	9.66e-05	0.00239	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by EGFR—KIT—testicular cancer	9.6e-05	0.00238	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by EGFR—KIT—testicular cancer	9.6e-05	0.00238	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	9.51e-05	0.00236	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	9.51e-05	0.00236	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by PDGF—KIT—testicular cancer	9.47e-05	0.00235	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by PDGF—KIT—testicular cancer	9.47e-05	0.00235	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—BCL10—testicular cancer	9.45e-05	0.00234	CbGpPWpGaD
Fluphenazine—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	9.34e-05	0.00231	CbGpPWpGaD
Fluphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	9.34e-05	0.00231	CbGpPWpGaD
Fluphenazine—CALM3—B Cell Activation—KIT—testicular cancer	9.27e-05	0.0023	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—BCL10—testicular cancer	9.15e-05	0.00227	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—BCL10—testicular cancer	9.15e-05	0.00227	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—BCL10—testicular cancer	9.08e-05	0.00225	CbGpPWpGaD
Fluphenazine—CALM1—B Cell Activation—KIT—testicular cancer	8.96e-05	0.00222	CbGpPWpGaD
Fluphenazine—CALM2—B Cell Activation—KIT—testicular cancer	8.96e-05	0.00222	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—INSL3—testicular cancer	8.93e-05	0.00221	CbGpPWpGaD
Fluphenazine—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	8.87e-05	0.0022	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—BCL10—testicular cancer	8.78e-05	0.00218	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—BCL10—testicular cancer	8.78e-05	0.00218	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—INSL3—testicular cancer	8.78e-05	0.00218	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—INSL3—testicular cancer	8.76e-05	0.00217	CbGpPWpGaD
Fluphenazine—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	8.58e-05	0.00213	CbGpPWpGaD
Fluphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	8.58e-05	0.00213	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—INSL3—testicular cancer	7.99e-05	0.00198	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by NGF—FGFR3—testicular cancer	7.43e-05	0.00184	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—INSL3—testicular cancer	7.29e-05	0.00181	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by NGF—FGFR3—testicular cancer	7.19e-05	0.00178	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by NGF—FGFR3—testicular cancer	7.19e-05	0.00178	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—INSL3—testicular cancer	7.05e-05	0.00175	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—INSL3—testicular cancer	7.05e-05	0.00175	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by NGF—KIT—testicular cancer	6.82e-05	0.00169	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by NGF—KIT—testicular cancer	6.6e-05	0.00163	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by NGF—KIT—testicular cancer	6.6e-05	0.00163	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—KITLG—testicular cancer	5.7e-05	0.00141	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—KITLG—testicular cancer	5.51e-05	0.00137	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—KITLG—testicular cancer	5.51e-05	0.00137	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—BCL10—testicular cancer	5.51e-05	0.00136	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—KITLG—testicular cancer	5.47e-05	0.00136	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—BCL10—testicular cancer	5.33e-05	0.00132	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—BCL10—testicular cancer	5.33e-05	0.00132	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—KITLG—testicular cancer	5.3e-05	0.00131	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—KITLG—testicular cancer	5.3e-05	0.00131	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.19e-05	0.00129	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—H2AFZ—testicular cancer	4.4e-05	0.00109	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—STK11—testicular cancer	4.37e-05	0.00108	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—FGFR3—testicular cancer	4.24e-05	0.00105	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—HPGDS—testicular cancer	4.19e-05	0.00104	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—FGFR3—testicular cancer	4.1e-05	0.00102	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—FGFR3—testicular cancer	4.1e-05	0.00102	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—FGFR3—testicular cancer	4.07e-05	0.00101	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—KITLG—testicular cancer	4.04e-05	0.001	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—FGFR3—testicular cancer	3.94e-05	0.000975	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—FGFR3—testicular cancer	3.94e-05	0.000975	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—KIT—testicular cancer	3.89e-05	0.000964	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—HPGDS—testicular cancer	3.84e-05	0.000952	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—HPGDS—testicular cancer	3.82e-05	0.000946	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—H2AFZ—testicular cancer	3.78e-05	0.000938	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—KIT—testicular cancer	3.76e-05	0.000932	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—KIT—testicular cancer	3.76e-05	0.000932	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—STK11—testicular cancer	3.76e-05	0.000932	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—KIT—testicular cancer	3.74e-05	0.000925	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—H2AFZ—testicular cancer	3.73e-05	0.000925	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—STK11—testicular cancer	3.71e-05	0.00092	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—HPGDS—testicular cancer	3.69e-05	0.000915	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—HPGDS—testicular cancer	3.69e-05	0.000915	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—KIT—testicular cancer	3.61e-05	0.000895	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—KIT—testicular cancer	3.61e-05	0.000895	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KITLG—testicular cancer	3.48e-05	0.000863	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KITLG—testicular cancer	3.43e-05	0.000851	CbGpPWpGaD
Fluphenazine—CALM3—Disease—H2AFZ—testicular cancer	3.33e-05	0.000826	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KITLG—testicular cancer	3.32e-05	0.000823	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—H2AFZ—testicular cancer	3.25e-05	0.000806	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—H2AFZ—testicular cancer	3.24e-05	0.000802	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—STK11—testicular cancer	3.24e-05	0.000802	CbGpPWpGaD
Fluphenazine—CALM2—Disease—H2AFZ—testicular cancer	3.22e-05	0.000799	CbGpPWpGaD
Fluphenazine—CALM1—Disease—H2AFZ—testicular cancer	3.22e-05	0.000799	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—STK11—testicular cancer	3.22e-05	0.000797	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KITLG—testicular cancer	3.21e-05	0.000796	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KITLG—testicular cancer	3.21e-05	0.000796	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KITLG—testicular cancer	3.07e-05	0.00076	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—STK11—testicular cancer	3.04e-05	0.000753	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—FGFR3—testicular cancer	3.01e-05	0.000745	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KITLG—testicular cancer	2.99e-05	0.000742	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KITLG—testicular cancer	2.98e-05	0.000738	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KITLG—testicular cancer	2.97e-05	0.000735	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KITLG—testicular cancer	2.97e-05	0.000735	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—HPGDS—testicular cancer	2.89e-05	0.000717	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—H2AFZ—testicular cancer	2.86e-05	0.000708	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STK11—testicular cancer	2.84e-05	0.000704	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—H2AFZ—testicular cancer	2.81e-05	0.000696	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—H2AFZ—testicular cancer	2.8e-05	0.000695	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STK11—testicular cancer	2.79e-05	0.000692	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—STK11—testicular cancer	2.79e-05	0.000692	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STK11—testicular cancer	2.79e-05	0.000691	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—STK11—testicular cancer	2.77e-05	0.000687	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—KIT—testicular cancer	2.76e-05	0.000684	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—HPGDS—testicular cancer	2.73e-05	0.000676	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—STK11—testicular cancer	2.68e-05	0.000665	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—STK11—testicular cancer	2.68e-05	0.000665	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KITLG—testicular cancer	2.63e-05	0.000651	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—FGFR3—testicular cancer	2.59e-05	0.000641	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KITLG—testicular cancer	2.59e-05	0.000641	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KITLG—testicular cancer	2.58e-05	0.000639	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—H2AFZ—testicular cancer	2.56e-05	0.000634	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—FGFR3—testicular cancer	2.55e-05	0.000632	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STK11—testicular cancer	2.54e-05	0.00063	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—FGFR3—testicular cancer	2.47e-05	0.000611	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—FGFR3—testicular cancer	2.39e-05	0.000591	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—FGFR3—testicular cancer	2.39e-05	0.000591	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KIT—testicular cancer	2.38e-05	0.000589	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KITLG—testicular cancer	2.35e-05	0.000583	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KIT—testicular cancer	2.34e-05	0.000581	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—H2AFZ—testicular cancer	2.33e-05	0.000578	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STK11—testicular cancer	2.32e-05	0.000575	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—HPGDS—testicular cancer	2.31e-05	0.000572	CbGpPWpGaD
Fluphenazine—CALM3—Disease—FGFR3—testicular cancer	2.28e-05	0.000565	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KIT—testicular cancer	2.27e-05	0.000561	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—H2AFZ—testicular cancer	2.26e-05	0.000559	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—H2AFZ—testicular cancer	2.26e-05	0.000559	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STK11—testicular cancer	2.24e-05	0.000556	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STK11—testicular cancer	2.24e-05	0.000556	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—FGFR3—testicular cancer	2.22e-05	0.000551	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—FGFR3—testicular cancer	2.21e-05	0.000548	CbGpPWpGaD
Fluphenazine—CALM2—Disease—FGFR3—testicular cancer	2.2e-05	0.000546	CbGpPWpGaD
Fluphenazine—CALM1—Disease—FGFR3—testicular cancer	2.2e-05	0.000546	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KIT—testicular cancer	2.19e-05	0.000543	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KIT—testicular cancer	2.19e-05	0.000543	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KITLG—testicular cancer	2.15e-05	0.000532	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—STK11—testicular cancer	2.1e-05	0.000521	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KIT—testicular cancer	2.09e-05	0.000518	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KITLG—testicular cancer	2.08e-05	0.000515	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KITLG—testicular cancer	2.08e-05	0.000515	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KIT—testicular cancer	2.04e-05	0.000506	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KIT—testicular cancer	2.03e-05	0.000503	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KIT—testicular cancer	2.02e-05	0.000501	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KIT—testicular cancer	2.02e-05	0.000501	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—STK11—testicular cancer	1.98e-05	0.000491	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—FGFR3—testicular cancer	1.95e-05	0.000484	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—FGFR3—testicular cancer	1.92e-05	0.000476	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—FGFR3—testicular cancer	1.92e-05	0.000475	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KIT—testicular cancer	1.79e-05	0.000444	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KIT—testicular cancer	1.76e-05	0.000437	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KIT—testicular cancer	1.76e-05	0.000436	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—FGFR3—testicular cancer	1.75e-05	0.000433	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—STK11—testicular cancer	1.68e-05	0.000416	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KIT—testicular cancer	1.61e-05	0.000398	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—FGFR3—testicular cancer	1.6e-05	0.000395	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—FGFR3—testicular cancer	1.54e-05	0.000382	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—FGFR3—testicular cancer	1.54e-05	0.000382	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KIT—testicular cancer	1.46e-05	0.000363	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KIT—testicular cancer	1.42e-05	0.000351	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KIT—testicular cancer	1.42e-05	0.000351	CbGpPWpGaD
